Why the study?
Does RV-2D strain predict adverse clinical outcomes in patients with chronic heart failure?
Population
161 participants including 43 controls and 118 stable chronic heart failure patients
Design
Cohort
Follow-up
mean 37±14 months
Authors
Loading...
May refine risk stratification in chronic HF; hypothesis-generating and requires prospective validation before clinical adoption.
Does RV-2D strain predict adverse clinical outcomes in patients with chronic heart failure?
RV-2D strain is a strong independent predictor of severe adverse events in patients with chronic heart failure, potentially superior to other RV or LV echocardiographic variables.
Guendouz et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: